Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of obesity on COX-1 and COX-2 acetylation by aspirin in colorectal cancer
2021-005999-18Phase 2Active
- Sponsor
- IIS Aragón
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin in colorectal cancer (CRC) (2 arms), sponsored by IIS Aragón. Primary endpoint: Platelet and colonic COX enzyme acetylation. Started Feb 2022; status: active.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2021-005999-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005999-18.